Gleamer
Seedtable Score
52
Startups
2
Funding Rounds
5
Investors
$38.26m
Money raised
Overview
Gleamer, based in Paris, has significant potential by providing AI software to improve the accuracy and efficiency of radiologists in interpreting medical images. Focusing on health tech, Gleamer addresses challenges in radiology such as diagnostic errors, slow processing times, and high workloads. Their B2B model targets healthcare institutions directly, ensuring steady demand. Supported by prominent investors, Gleamer's AI technology could revolutionize medical imaging, reduce human error, and lead to better patient outcomes. This specific focus on radiology allows Gleamer to carve out a niche market, positioning itself as an essential tool for modern healthcare facilities.
- Website: https://gleamer.ai
- Business model: b2b
- Company size: 1 - 11 employees
- Headquarters: Paris, France
- Founded: 2017
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Gleamer has raised a total of $38.26m in funding over 2 rounds.
Key Insights:
- Series A: $8.72m
- Series B: $29.54m
Gleamer Series A (2020, $8M)
$8.72m
Gleamer Series B (2023, $29M)
$29.54m